@walletair8
Active 3 years, 7 months ago
Background: An updated monetary evaluation has been performed to check the cost-effectiveness in the four tumor necrosis issue (TNF)-alpha inhibitors adalimumab, etanercept, golimumab and infliximab within productive, progressive psoriatic joint disease (PsA) wherever reply to regular treatment method continues to be inferior.
Methods: A […] View
Sorry, there was no activity found. Please try a different filter.

